Literature DB >> 14668482

Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes.

Silvia Di Agostino1, Monica Fedele, Paolo Chieffi, Alfredo Fusco, Pellegrino Rossi, Raffaele Geremia, Claudio Sette.   

Abstract

The mitogen-activated protein kinase (MAPK) pathway is required for maintaining the chromatin condensed during the two meiotic divisions and to avoid a second round of DNA duplication. However, molecular targets of the MAPK pathway on chromatin have not yet been identified. Here, we show that the architectural chromatin protein HMGA2 is highly expressed in male meiotic cells. Furthermore, Nek2, a serine-threonine kinase activated by the MAPK pathway in mouse pachytene spermatocytes, directly interacts with HMGA2 in vitro and in mouse spermatocytes. The interaction does not depend on the activity of Nek2 and seems constitutive. On progression from pachytene to metaphase, Nek2 is activated and HMGA2 is phosphorylated in an MAPK-dependent manner. We also show that Nek2 phosphorylates in vitro HMGA2 and that this phosphorylation decreases the affinity of HMGA2 for DNA and might favor its release from the chromatin. Indeed, we find that most HMGA2 associates with chromatin in mouse pachytene spermatocytes, whereas it is excluded from the chromatin upon the G2/M progression. Because hmga2-/- mice are sterile and show a dramatic impairment of spermatogenesis, it is possible that the functional interaction between HMGA2 and Nek2 plays a crucial role in the correct process of chromatin condensation in meiosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668482      PMCID: PMC363112          DOI: 10.1091/mbc.e03-09-0638

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  42 in total

1.  The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes.

Authors:  T Choi; K Fukasawa; R Zhou; L Tessarollo; K Borror; J Resau; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Murine NIMA-related kinases are expressed in patterns suggesting distinct functions in gametogenesis and a role in the nervous system.

Authors:  E Arama; A Yanai; G Kilfin; A Bernstein; B Motro
Journal:  Oncogene       Date:  1998-04-09       Impact factor: 9.867

Review 3.  Sexual dimorphism in the regulation of mammalian meiosis.

Authors:  M A Handel; J J Eppig
Journal:  Curr Top Dev Biol       Date:  1998       Impact factor: 4.897

Review 4.  Meiotic chromosomes: it takes two to tango.

Authors:  G S Roeder
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

5.  The in vivo expression pattern of mouse Nek2, a NIMA-related kinase, indicates a role in both mitosis and meiosis.

Authors:  K Tanaka; M Parvinen; E A Nigg
Journal:  Exp Cell Res       Date:  1997-12-15       Impact factor: 3.905

6.  A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators.

Authors:  A M Fry; P Meraldi; E A Nigg
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

7.  Acquisition of competence to condense metaphase I chromosomes during spermatogenesis.

Authors:  J Cobb; B Cargile; M A Handel
Journal:  Dev Biol       Date:  1999-01-01       Impact factor: 3.582

8.  The NIMA-related kinase 2, Nek2, is expressed in specific stages of the meiotic cell cycle and associates with meiotic chromosomes.

Authors:  K Rhee; D J Wolgemuth
Journal:  Development       Date:  1997-06       Impact factor: 6.868

9.  C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2.

Authors:  A M Fry; T Mayor; P Meraldi; Y D Stierhof; K Tanaka; E A Nigg
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

10.  Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse.

Authors:  M H Verlhac; J Z Kubiak; M Weber; G Géraud; W H Colledge; M J Evans; B Maro
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  36 in total

Review 1.  "Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.

Authors:  Gabriela Vaz Meirelles; Arina Marina Perez; Edmárcia Elisa de Souza; Fernanda Luisa Basei; Priscila Ferreira Papa; Talita Diniz Melo Hanchuk; Vanessa Bomfim Cardoso; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2014-05-26

Review 2.  Targeting NEK2 as a promising therapeutic approach for cancer treatment.

Authors:  Yanfen Fang; Xiongwen Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Discovery of potent NEK2 inhibitors as potential anticancer agents using structure-based exploration of NEK2 pharmacophoric space coupled with QSAR analyses.

Authors:  Mohammad A Khanfar; Fahmy Banat; Shada Alabed; Saja Alqtaishat
Journal:  Mol Divers       Date:  2016-09-06       Impact factor: 2.943

4.  Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.

Authors:  Huajie Liu; Bin Liu; Xianzeng Hou; Bo Pang; Pengbo Guo; Wanli Jiang; Qian Ding; Rui Zhang; Tao Xin; Hua Guo; Shangchen Xu; Qi Pang
Journal:  J Neurooncol       Date:  2017-03-21       Impact factor: 4.130

5.  Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization.

Authors:  Daniel K Whelligan; Savade Solanki; Dawn Taylor; Douglas W Thomson; Kwai-Ming J Cheung; Kathy Boxall; Corine Mas-Droux; Caterina Barillari; Samantha Burns; Charles G Grummitt; Ian Collins; Rob L M van Montfort; G Wynne Aherne; Richard Bayliss; Swen Hoelder
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

Review 6.  Interplay between HMGA and TP53 in cell cycle control along tumor progression.

Authors:  Nathalia Meireles Da Costa; Antonio Palumbo; Marco De Martino; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cell Mol Life Sci       Date:  2020-09-12       Impact factor: 9.261

7.  SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

Authors:  Xuefei Cao; Carlos Clavijo; Xu Li; H Helen Lin; Yuan Chen; Hsiu-Ming Shih; David K Ann
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  STRA8 shuttles between nucleus and cytoplasm and displays transcriptional activity.

Authors:  Marianna Tedesco; Gina La Sala; Federica Barbagallo; Massimo De Felici; Donatella Farini
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  Biomarker function of HMGA2 in ultraviolet-induced skin cancer development.

Authors:  Wootae Ha; Amanda Hinde; Lillian Xie; Megan H Trager; Liang Liu
Journal:  Exp Dermatol       Date:  2020-09-22       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.